Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin
Peroxisome proliferator-activated receptor α (PPARα) plays a role in the pathogenesis of cardiac hypertrophy, although its underlying mechanism remains unclear. The purpose of this study was to evaluate the effect of PPARα activation on endothelin-1- (ET-1-) caused cardiomyocyte hypertrophy and expl...
Saved in:
Main Authors: | Hsu-Lung Jen, Po-Len Liu, Yung-Hsiang Chen, Wei-Hsian Yin, Jaw-Wen Chen, Shing-Jong Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2016/5609121 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhanced Hepatocarcinogenicity Due to Agonists of Peroxisome Proliferator-Activated Receptors in Senescent Rats: Role of Peroxisome Proliferation, Cell Proliferation, and Apoptosis
by: Jihan Youssef, et al.
Published: (2002-01-01) -
Free fatty acid receptor 2 promotes cardiomyocyte hypertrophy by activating STAT3 and GATA4
by: Hui Gao, et al.
Published: (2022-03-01) -
Peroxisome Proliferator-Activated Receptors in Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2007-01-01) -
Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
by: Shinji Kume, et al.
Published: (2008-01-01) -
Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
by: Sander Kersten
Published: (2008-01-01)